Abstract
Plant-based diets are a great source of protease inhibitors (PIs). Two of the most well-known families of PIs are Bowman-Birk inhibitors (BBI) and Kunitz-type inhibitors (KTI). The first group acts mainly on trypsin, chymotrypsin, and elastase; the second is on serine, cysteine, and aspartic proteases. PIs can retard or inhibit the catalytic action of enzymes; therefore, they are considered non-nutritional compounds; nevertheless, animal studies and cell line experiments showed promising results of PIs in treating human illnesses such as obesity, cardiovascular diseases, autoimmune diseases, inflammatory processes, and different types of cancer (gastric, colorectal, breast, and lung cancer). Anticarcinogenic activity's proposed mechanisms of action comprise several inhibitory effects at different molecular levels, i.e., transcription, post-transcription, translation, post-translation, and secretion of cancer cells. This work reviews the potential therapeutic applications of PIs as anticarcinogenic and anti-inflammatory agents in human diseases and the mechanisms by which they exert these effects.
Similar content being viewed by others
References
Hellinger R, Gruber CW (2019) Peptide-based protease inhibitors from plants. Drug Discov Today 24(9):1877–1889. https://doi.org/10.1016/j.drudis.2019.05.026
Harish BS, Uppuluri KB (2018) Microbial serine protease inhibitors and their therapeutic applications. Int J Biol Macromol 107(Pt B):1373–1387. https://doi.org/10.1016/j.ijbiomac.2017.09.115
Clemente M, Corigliano MG, Pariani SA, Sánchez-López EF, Sander VA, Ramos-Duarte VA (2019) Plant serine protease inhibitors: biotechnology application in agriculture and molecular farming. Int J Mol Sci 20(6). https://doi.org/10.3390/ijms20061345
Castro HC, Abreu PA, Geraldo RB, Martins RC, dos Santos R, Loureiro NI, Cabral LM, Rodrigues CR (2011) Looking at the proteases from a simple perspective. J Mol Recognit 24(2):165–181. https://doi.org/10.1002/jmr.1091
Bauvois B (2004) Transmembrane proteases in cell growth and invasion: new contributors to angiogenesis? Oncogene 23(2):317–329. https://doi.org/10.1038/sj.onc.1207124
Petzold HE, Zhao M, Beers EP (2012) Expression and functions of proteases in vascular tissues. Physiol Plant 145(1):121–129. https://doi.org/10.1111/j.1399-3054.2011.01538.x
Moffitt KL, Martin SL, Walker B (2010) Proteases implicated in apoptosis: old and new. J Pharm Pharmacol 62(5):563–576. https://doi.org/10.1211/jpp.62.05.0002
Regulski M, Regulska K, Stanisz BJ, Murias M, Gieremek P, Wzgarda A, Niznik B (2015) Chemistry and pharmacology of Angiotensin-converting enzyme inhibitors. Curr Pharm Des 21(13):1764–1775. https://doi.org/10.2174/1381612820666141112160013
Srikanth S, Chen Z (2016) Plant Protease inhibitors in therapeutics-focus on cancer therapy. Front Pharmacol 7:470. https://doi.org/10.3389/fphar.2016.00470
Rahate KA, Madhumita M, Prabhakar PK (2021) Nutritional composition, antinutritional factors, pretreatments-cum-processing impact and food formulation potential of faba bean (Vicia faba L.): a comprehensive review. LWT 138:110796. https://doi.org/10.1016/j.lwt.2020.110796
Mosolov VV, Valueva TA (2005) Proteinase inhibitors and their function in plants:a review. Appl Biochem Microbiol 41(3):227–246. https://doi.org/10.1007/s10438-005-0040-6
Losso JN (2008) The biochemical and functional food properties of the bowman-birk inhibitor. Crit Rev Food Sci Nutr 48(1):94–118. https://doi.org/10.1080/10408390601177589
Gitlin-Domagalska A, Maciejewska A, Dębowski D (2020) Bowman-Birk inhibitors: insights into family of multifunctional proteins and peptides with potential therapeutical applications. Pharmaceuticals (Basel) 13(12). https://doi.org/10.3390/ph13120421
Oliva ML, Silva MC, Sallai RC, Brito MV, Sampaio MU (2010) A novel subclassification for Kunitz proteinase inhibitors from leguminous seeds. Biochimie 92(11):1667–1673. https://doi.org/10.1016/j.biochi.2010.03.021
Kuhar K, Kansal R, Subrahmanyam B, Koundal K, Miglani K, Gupta V (2013) A Bowman-Birk protease inhibitor with antifeedant and antifungal activity from Dolichos biflorus. Acta Physiol Plant 35(6):1887–1903. https://doi.org/10.1007/s11738-013-1227-8
Machado RJ, Monteiro NK, Migliolo L, Silva ON, Pinto MF, Oliveira AS, Franco OL, Kiyota S, Bemquerer MP, Uchoa AF, Morais AH, Santos EA (2013) Characterization and pharmacological properties of a novel multifunctional Kunitz inhibitor from Erythrina velutina seeds. PLoS ONE 8(5):e63571. https://doi.org/10.1371/journal.pone.0063571
Guerra Y, Valiente P, Pons T, Berry C, Rudiño-Piñera E (2016) Structures of a bi-functional Kunitz-type STI family inhibitor of serine and aspartic proteases: Could the aspartic protease inhibition have evolved from a canonical serine protease-binding loop? J Struct Biol 195(2):259–271. https://doi.org/10.1016/j.jsb.2016.06.014
Clemente A, Arques Mdel C (2014) Bowman-Birk inhibitors from legumes as colorectal chemopreventive agents. World J Gastroenterol 20(30):10305–10315. https://doi.org/10.3748/wjg.v20.i30.10305
Avilés-Gaxiola S, Chuck-Hernández C, Rocha-Pizaña MR, García-Lara S, López-Castillo LM, Serna-Saldívar SO (2018) Effect of thermal processing and reducing agents on trypsin inhibitor activity and functional properties of soybean and chickpea protein concentrates. LWT 98:629–634. https://doi.org/10.1016/j.lwt.2018.09.023
Nikmaram N, Leong SY, Koubaa M, Zhu Z, Barba FJ, Greiner R, Oey I, Roohinejad S (2017) Effect of extrusion on the antinutritional factors of food products: an overview. Food Control 79:62–73. https://doi.org/10.1016/j.foodcont.2017.03.027
Popova A, Mihaylova D (2019) Antinutrients in plant-based foods: a review. Open Biotechnol J 13(1). https://doi.org/10.2174/1874070701913010068
Pusztai A, Bardocz S, Martín-Cabrejas MA (2004) The mode of action of ANFs on the gastrointestinal tract and its microflora. In: Publishers WA (ed) Recent advances of research in antinutritional factors in legume seeds and oilseeds, vol 110. Wageningen Academic Publishers, Wageningen, The Netherlands, pp 87–100. https://doi.org/10.3920/978-90-8686-524-6
Kiran KS, Padmaja G (2003) Inactivation of trypsin inhibitors in sweet potato and taro tubers during processing. Plant Foods Hum Nutr 58(2):153–163. https://doi.org/10.1023/a:1024476513899
He H, Li X, Kong X, Hua Y, Chen Y (2017) Heat-induced inactivation mechanism of soybean Bowman-Birk inhibitors. Food Chem 232:712–720. https://doi.org/10.1016/j.foodchem.2017.04.061
Chen Y, Xu Z, Zhang C, Kong X, Hua Y (2014) Heat-induced inactivation mechanisms of Kunitz trypsin inhibitor and Bowman-Birk inhibitor in soymilk processing. Food Chem 154:108–116. https://doi.org/10.1016/j.foodchem.2013.12.092
Samtiya M, Aluko RE, Dhewa T (2020) Plant food antinutritional factors and their reduction strategies: an overview. Food Prod Process Nutr 2(1):6. https://doi.org/10.1186/s43014-020-0020-5
Pedrosa MM, Varela A, Domínguez-Timón F, Tovar CA, Moreno HM, Borderías AJ, Díaz MT (2020) Comparison of bioactive compounds content and techno-functional properties of pea and bean flours and their protein isolates. Plant Foods Hum Nutr 75(4):642–650. https://doi.org/10.1007/s11130-020-00866-4
Fook JM, Macedo LL, Moura GE, Teixeira FM, Oliveira AS, Queiroz AF, Sales MP (2005) A serine proteinase inhibitor isolated from Tamarindus indica seeds and its effects on the release of human neutrophil elastase. Life Sci 76(25):2881–2891. https://doi.org/10.1016/j.lfs.2004.10.053
Mello GC, Desouza IA, Marangoni S, Novello JC, Antunes E, Macedo MLR (2006) Oedematogenic activity induced by Kunitz-type inhibitors from Dimorphandra mollis seeds. Toxicon 47(2):150–155. https://doi.org/10.1016/j.toxicon.2005.10.003
Oliva ML, Souza-Pinto JC, Batista IF, Araujo MS, Silveira VF, Auerswald EA, Mentele R, Eckerskorn C, Sampaio MU, Sampaio CA (2000) Leucaena leucocephala serine proteinase inhibitor: primary structure and action on blood coagulation, kinin release and rat paw edema. Biochim Biophys Acta 1477(1–2):64–74. https://doi.org/10.1016/s0167-4838(99)00285-x
de Freitas MAG, Amaral NO, Álvares ACM, de Oliveira SA, Mehdad A, Honda DE, Bessa ASM, Ramada MHS, Naves LM, Pontes CNR, Castro CH, Pedrino GR, de Freitas SM (2020) Blood pressure-lowering effects of a Bowman-Birk inhibitor and its derived peptides in normotensive and hypertensive rats. Sci Rep 10(1):11680. https://doi.org/10.1038/s41598-020-66624-3
Kim JY, Park SC, Hwang I, Cheong H, Nah JW, Hahm KS, Park Y (2009) Protease inhibitors from plants with antimicrobial activity. Int J Mol Sci 10(6):2860–2872. https://doi.org/10.3390/ijms10062860
Amancha KP, Hussain A (2015) Effect of protease inhibitors on pulmonary bioavailability of therapeutic proteins and peptides in the rat. Eur J Pharm Sci 68:1–10. https://doi.org/10.1016/j.ejps.2014.11.008
Oliveira de Lima C, Piuvezam G, Leal Lima Maciel B, de Araújo H, Morais A (2019) Trypsin inhibitors: promising candidate satietogenic proteins as complementary treatment for obesity and metabolic disorders? J Enzyme Inhib Med Chem 34(1):405–419. https://doi.org/10.1080/14756366.2018.1542387
Dias GB, Gomes VM, Pereira UZ, Ribeiro SF, Carvalho AO, Rodrigues R, Machado OL, Fernandes KV, Ferreira AT, Perales J, Da Cunha M (2013) Isolation, characterization and antifungal activity of proteinase inhibitors from Capsicum chinense Jacq. Seeds Protein J 32(1):15–26. https://doi.org/10.1007/s10930-012-9456-z
Araújo NMS, Dias LP, Costa HPS, Sousa DOB, Vasconcelos IM, de Morais GA, Oliveira JTA (2019) ClTI, a Kunitz trypsin inhibitor purified from Cassia leiandra Benth. seeds, exerts a candidicidal effect on Candida albicans by inducing oxidative stress and necrosis. Biochim Biophys Acta Biomembr 1861(11):183032. https://doi.org/10.1016/j.bbamem.2019.183032
Nabi M, Bhat A, Abeer Rasool SU, Ashraf S, Maqbool R, Ahmad Ganie S, Amin S (2018) Physio-chemical characterization and anti-microbial activity of serine protease inhibitors purified from the Sophora japonica Seeds. Pak J Biol Sci 21(9):432–440. https://doi.org/10.3923/pjbs.2018.432.440
Serquiz AC, Machado RJ, Serquiz RP, Lima VC, de Carvalho FM, Carneiro MA, Maciel BL, Uchôa AF, Santos EA, Morais AH (2016) Supplementation with a new trypsin inhibitor from peanut is associated with reduced fasting glucose, weight control, and increased plasma CCK secretion in an animal model. J Enzyme Inhib Med Chem 31(6):1261–1269. https://doi.org/10.3109/14756366.2015.1103236
Chandra R, Liddle RA (2007) Cholecystokinin. Curr Opin Endocrinol Diabetes Obes 14(1):63–67. https://doi.org/10.1097/MED.0b013e3280122850
Costa HP, Oliveira JT, Sousa DO, Morais JK, Moreno FB, Monteiro-Moreira AC, Viegas RA, Vasconcelos IM (2014) JcTI-I: a novel trypsin inhibitor from Jatropha curcas seed cake with potential for bacterial infection treatment. Front Microbiol 5:5. https://doi.org/10.3389/fmicb.2014.00005
Martins TF, Vasconcelos IM, Silva RGG, Silva FDA, Souza PFN, Varela ALN, Albuquerque LM, Oliveira JTA (2018) A Bowman-Birk Inhibitor from the Seeds of Luetzelburgia auriculata Inhibits Staphylococcus aureus Growth by Promoting Severe Cell Membrane Damage. J Nat Prod 81(7):1497–1507. https://doi.org/10.1021/acs.jnatprod.7b00545
da Cunha Morales Álvares A, Schwartz EF, Amaral NO, Trindade NR, Pedrino GR, Silva LP, de Freitas SM, (2014) Bowman-Birk protease inhibitor from Vigna unguiculata seeds enhances the action of bradykinin-related peptides. Molecules 19(11):17536–17558. https://doi.org/10.3390/molecules191117536
Qi RF, Song ZW, Chi CW (2005) Structural features and molecular evolution of Bowman-Birk protease inhibitors and their potential application. Acta Biochim Biophys Sin (Shanghai) 37(5):283–292. https://doi.org/10.1111/j.1745-7270.2005.00048.x
Touil T, Ciric B, Ventura E, Shindler KS, Gran B, Rostami A (2008) Bowman-Birk inhibitor suppresses autoimmune inflammation and neuronal loss in a mouse model of multiple sclerosis. J Neurol Sci 271(1–2):191–202. https://doi.org/10.1016/j.jns.2008.04.030
Dai H, Ciric B, Zhang GX, Rostami A (2012) Interleukin-10 plays a crucial role in suppression of experimental autoimmune encephalomyelitis by Bowman-Birk inhibitor. J Neuroimmunol 245(1–2):1–7. https://doi.org/10.1016/j.jneuroim.2012.01.005
Safavi F, Rostami A (2012) Role of serine proteases in inflammation: Bowman-Birk protease inhibitor (BBI) as a potential therapy for autoimmune diseases. Exp Mol Pathol 93(3):428–433. https://doi.org/10.1016/j.yexmp.2012.09.014
Selma-Gracia R, Haros CM, Laparra JM (2020) Kinetic approach to the influence of chia flour on glucose bioaccessibility from hydrothermally treated maize and quinoa starch. Plant Foods Hum Nutr 75(4):592–598. https://doi.org/10.1007/s11130-020-00854-8
Li J, Ye L, Cook DR, Wang X, Liu J, Kolson DL, Persidsky Y, Ho WZ (2011) Soybean-derived Bowman-Birk inhibitor inhibits neurotoxicity of LPS-activated macrophages. J Neuroinflammation 8:15. https://doi.org/10.1186/1742-2094-8-15
Arbogast S, Smith J, Matuszczak Y, Hardin BJ, Moylan JS, Smith JD, Ware J, Kennedy AR, Reid MB (2007) Bowman-Birk inhibitor concentrate prevents atrophy, weakness, and oxidative stress in soleus muscle of hindlimb-unloaded mice. J Appl Physiol 102(3):956–964. https://doi.org/10.1152/japplphysiol.00538.2006
Mehdad A, Brumana G, Souza AA, Barbosa J, Ventura MM, de Freitas SM (2016) A Bowman-Birk inhibitor induces apoptosis in human breast adenocarcinoma through mitochondrial impairment and oxidative damage following proteasome 20S inhibition. Cell Death Discov 2:15067. https://doi.org/10.1038/cddiscovery.2015.67
Lichtenstein GR, Deren JJ, Katz S, Lewis JD, Kennedy AR, Ware JH (2008) Bowman-Birk inhibitor concentrate: a novel therapeutic agent for patients with active ulcerative colitis. Dig Dis Sci 53(1):175–180. https://doi.org/10.1007/s10620-007-9840-2
Kennedy AR, Billings PC, Wan XS, Newberne PM (2002) Effects of Bowman-Birk inhibitor on rat colon carcinogenesis. Nutr Cancer 43(2):174–186. https://doi.org/10.1207/s15327914nc432_8
de Paula CA, de Abreu Vieira PM, Silva KT, de Sá Cota RG, Carneiro CM, Castro-Borges W, de Andrade MH (2012) Bowman-Birk inhibitors, proteasome peptidase activities and colorectal pre neoplasias induced by 1,2-dimethylhydrazine in Swiss mice. Food Chem Toxicol 50(5):1405–1412. https://doi.org/10.1016/j.fct.2012.01.036
Clemente A, Moreno FJ, Marín-Manzano Mdel C, Jiménez E, Domoney C (2010) The cytotoxic effect of Bowman-Birk isoinhibitors, IBB1 and IBBD2, from soybean (Glycine max) on HT29 human colorectal cancer cells is related to their intrinsic ability to inhibit serine proteases. Mol Nutr Food Res 54(3):396–405. https://doi.org/10.1002/mnfr.200900122
Joanitti GA, Azevedo RB, Freitas SM (2010) Apoptosis and lysosome membrane permeabilization induction on breast cancer cells by an anticarcinogenic Bowman-Birk protease inhibitor from Vigna unguiculata seeds. Cancer Lett 293(1):73–81. https://doi.org/10.1016/j.canlet.2009.12.017
Armstrong WB, Taylor TH, Kennedy AR, Melrose RJ, Messadi DV, Gu M, Le AD, Perloff M, Civantos F, Goodwin WJ, Wirth LJ, Kerr AR, Meyskens FL Jr (2013) Bowman birk inhibitor concentrate and oral leukoplakia: a randomized phase IIb trial. Cancer Prev Res (Phila) 6(5):410–418. https://doi.org/10.1158/1940-6207.Capr-13-0004
Avilés-Gaxiola S, Gutiérrez-Grijalva EP, León-Felix J, Angulo-Escalante MA, Heredia JB (2020) Peptides in colorectal cancer: current state of knowledge. Plant Foods Hum Nutr 75(4):467–476. https://doi.org/10.1007/s11130-020-00856-6
Zhang L, Wan XS, Donahue JJ, Ware JH, Kennedy AR (1999) Effects of the Bowman-Birk inhibitor on clonogenic survival and cisplatin- or radiation-induced cytotoxicity in human breast, cervical, and head and neck cancer cells. Nutr Cancer 33(2):165–173. https://doi.org/10.1207/s15327914nc330208
Oster SK, Ho CSW, Soucie EL, Penn LZ (2002) The myc oncogene: marvelously complex. In: Advances in Cancer Research, vol 84. Academic Press, pp 81–154. https://doi.org/10.1016/S0065-230X(02)84004-0
Kang SM, Lim S, Won SJ, Shin YJ, Lim YS, Ahn BY, Hwang SB (2011) c-Fos regulates hepatitis C virus propagation. FEBS Lett 585(20):3236–3244. https://doi.org/10.1016/j.febslet.2011.08.041
Hanahan D, Weinberg RA (2011) Hallmarks of Cancer: The Next Generation. Cell 144(5):646–674. https://doi.org/10.1016/j.cell.2011.02.013
Huber V, Fais S, Iero M, Lugini L, Canese P, Squarcina P, Zaccheddu A, Colone M, Arancia G, Gentile M, Seregni E, Valenti R, Ballabio G, Belli F, Leo E, Parmiani G, Rivoltini L (2005) Human colorectal cancer cells induce T-cell death through release of proapoptotic microvesicles: role in immune escape. Gastroenterology 128(7):1796–1804. https://doi.org/10.1053/j.gastro.2005.03.045
Soreide K, Janssen EA, Körner H, Baak JP (2006) Trypsin in colorectal cancer: molecular biological mechanisms of proliferation, invasion, and metastasis. J Pathol 209(2):147–156. https://doi.org/10.1002/path.1999
Rakashanda S, Qazi AK, Majeed R, Rafiq S, Dar IM, Masood A, Hamid A, Amin S (2013) Antiproliferative activity of Lavatera cashmeriana- protease inhibitors towards human cancer cells. Asian Pac J Cancer Prev 14(6):3975–3978. https://doi.org/10.7314/apjcp.2013.14.6.3975
Fereidunian A, Sadeghalvad M, Oscoie MO, Mostafaie A (2014) Soybean Bowman-Birk protease inhibitor (BBI): identification of the mechanisms of BBI suppressive effect on growth of two adenocarcinoma cell lines: AGS and HT29. Arch Med Res 45(6):455–461. https://doi.org/10.1016/j.arcmed.2014.07.001
Miedzianka J, Pęksa A, Nemś A, Drzymała K, Zambrowicz A, Kowalczewski P (2020) Trypsin inhibitor, antioxidant and antimicrobial activities as well as chemical composition of potato sprouts originating from yellow- and colored-fleshed varieties. J Environ Sci Health B 55(1):42–51. https://doi.org/10.1080/03601234.2019.1657764
Kobayashi H (2013) Prevention of cancer and inflammation by soybean protease inhibitors. Front Biosci (Elite Ed) 5:966–973. https://doi.org/10.2741/e676
Cruz-Huerta E, Fernández-Tomé S, Arques MC, Amigo L, Recio I, Clemente A, Hernández-Ledesma B (2015) The protective role of the Bowman-Birk protease inhibitor in soybean lunasin digestion: the effect of released peptides on colon cancer growth. Food Funct 6(8):2626–2635. https://doi.org/10.1039/c5fo00454c
Kobayashi H, Suzuki M, Kanayama N, Terao T (2004) A soybean Kunitz trypsin inhibitor suppresses ovarian cancer cell invasion by blocking urokinase upregulation. Clin Exp Metastasis 21(2):159–166. https://doi.org/10.1023/b:clin.0000024751.73174.c2
Kennedy AR (1998) Chemopreventive agents: protease inhibitors. Pharmacol Ther 78(3):167–209. https://doi.org/10.1016/s0163-7258(98)00010-2
Kaneko S, Yamazaki T, Kohno K, Sato A, Kato K, Yano T (2019) Combination effect of Bowman-Birk inhibitor and α-Tocopheryl succinate on prostate cancer stem-like cells. J Nutr Sci Vitaminol (Tokyo) 65(3):272–277. https://doi.org/10.3177/jnsv.65.272
Kyani S, Akrami H, Mostafaei A, Akbari S, Salehi Z (2020) Inhibitory effect of Bowman-Birk protease inhibitor on autophagy in MDAMB231 breast cancer cell line. J Cancer Res Ther. https://doi.org/10.4103/jcrt.JCRT_622_18
Ragg EM, Galbusera V, Scarafoni A, Negri A, Tedeschi G, Consonni A, Sessa F, Duranti M (2006) Inhibitory properties and solution structure of a potent Bowman-Birk protease inhibitor from lentil (Lens culinaris L) seeds. Febs J 273(17):4024–4039. https://doi.org/10.1111/j.1742-4658.2006.05406.x
Clemente A, Gee JM, Johnson IT, Mackenzie DA, Domoney C (2005) Pea (Pisum sativum L.) protease inhibitors from the Bowman-Birk class influence the growth of human colorectal adenocarcinoma HT29 cells in vitro. J Agric Food Chem 53 (23):8979–8986. https://doi.org/10.1021/jf051528w
Chan YS, Zhang Y, Ng TB (2013) Brown Kidney Bean Bowman-Birk Trypsin Inhibitor is Heat and pH Stable and Exhibits Antiproliferative Activity. Appl Biochem Biotechnol 169(4):1306–1314. https://doi.org/10.1007/s12010-012-9998-8
Muricken DG (1804) Gowda LR (2010) Functional expression of horsegram (Dolichos biflorus) Bowman-Birk inhibitor and its self-association. Biochim Biophys Acta 7:1413–1423. https://doi.org/10.1016/j.bbapap.2010.02.012
Saito T, Sato H, Virgona N, Hagiwara H, Kashiwagi K, Suzuki K, Asano R, Yano T (2007) Negative growth control of osteosarcoma cell by Bowman-Birk protease inhibitor from soybean; involvement of connexin 43. Cancer Lett 253(2):249–257. https://doi.org/10.1016/j.canlet.2007.01.021
Oliveira de Lima VC, de Araújo Machado RJ, Vieira Monteiro NK, de Lyra IL, da Silva CC, Coelho Serquiz A, Silva de Oliveira A, da Silva Rufino FP, Leal Lima Maciel B, Ferreira Uchôa A, Antunes Dos Santos E, de Araújo Morais AH (2017) Gastroprotective and antielastase effects of protein inhibitors from Erythrina velutina seeds in an experimental ulcer model. Biochem Cell Biol 95(2):243–250. https://doi.org/10.1139/bcb-2016-0034
de Lumen BO (2005) Lunasin: a cancer-preventive soy peptide. Nutr Rev 63(1):16–21. https://doi.org/10.1111/j.1753-4887.2005.tb00106.x
Hsieh CC, Hernández-Ledesma B, Jeong HJ, Park JH, de Lumen BO (2010) Complementary roles in cancer prevention: protease inhibitor makes the cancer preventive peptide lunasin bioavailable. PLoS ONE 5(1):e8890. https://doi.org/10.1371/journal.pone.0008890
Acknowledgements
The authors thank the Instituto Politécnico Nacional for the financial support through grant SIP project 20210017.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no conflict of interest.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Cid-Gallegos, M.S., Corzo-Ríos, L.J., Jiménez-Martínez, C. et al. Protease Inhibitors from Plants as Therapeutic Agents- A Review. Plant Foods Hum Nutr 77, 20–29 (2022). https://doi.org/10.1007/s11130-022-00949-4
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11130-022-00949-4